PROCTER & GAMBLE HEALTH | MEDPLUS HEALTH SERVICES | PROCTER & GAMBLE HEALTH/ MEDPLUS HEALTH SERVICES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 137.5 | 25.2% | View Chart |
P/BV | x | 10.6 | 5.5 | 191.4% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH MEDPLUS HEALTH SERVICES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
MEDPLUS HEALTH SERVICES Mar-23 |
PROCTER & GAMBLE HEALTH/ MEDPLUS HEALTH SERVICES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,047 | 512.5% | |
Low | Rs | 3,883 | 570 | 681.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 382.0 | 193.9% | |
Earnings per share (Unadj.) | Rs | 138.2 | 4.2 | 3,291.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 19.4 | 799.1% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 122.4 | 365.6% | |
Shares outstanding (eoy) | m | 16.60 | 119.31 | 13.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.1 | 295.0% | |
Avg P/E ratio | x | 33.5 | 192.5 | 17.4% | |
P/CF ratio (eoy) | x | 29.8 | 41.6 | 71.6% | |
Price / Book Value ratio | x | 10.3 | 6.6 | 156.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 96,459 | 79.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 5,451 | 37.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 45,576 | 27.0% | |
Other income | Rs m | 184 | 461 | 39.9% | |
Total revenues | Rs m | 12,480 | 46,037 | 27.1% | |
Gross profit | Rs m | 3,247 | 2,814 | 115.4% | |
Depreciation | Rs m | 281 | 1,816 | 15.5% | |
Interest | Rs m | 8 | 987 | 0.8% | |
Profit before tax | Rs m | 3,142 | 472 | 666.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -29 | -2,880.0% | |
Profit after tax | Rs m | 2,295 | 501 | 458.0% | |
Gross profit margin | % | 26.4 | 6.2 | 427.7% | |
Effective tax rate | % | 27.0 | -6.2 | -432.3% | |
Net profit margin | % | 18.7 | 1.1 | 1,697.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 14,807 | 79.1% | |
Current liabilities | Rs m | 6,791 | 4,766 | 142.5% | |
Net working cap to sales | % | 40.0 | 22.0 | 181.7% | |
Current ratio | x | 1.7 | 3.1 | 55.5% | |
Inventory Days | Days | 263 | 10 | 2,725.9% | |
Debtors Days | Days | 343 | 1 | 49,575.6% | |
Net fixed assets | Rs m | 10,617 | 12,838 | 82.7% | |
Share capital | Rs m | 166 | 239 | 69.6% | |
"Free" reserves | Rs m | 7,265 | 14,369 | 50.6% | |
Net worth | Rs m | 7,431 | 14,607 | 50.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 27,645 | 80.8% | |
Interest coverage | x | 409.1 | 1.5 | 27,681.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 1.6 | 33.4% | |
Return on assets | % | 10.3 | 5.4 | 191.5% | |
Return on equity | % | 30.9 | 3.4 | 900.3% | |
Return on capital | % | 42.4 | 10.0 | 424.4% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 904 | 261.0% | |
From Investments | Rs m | -215 | 4,294 | -5.0% | |
From Financial Activity | Rs m | -985 | -1,702 | 57.8% | |
Net Cashflow | Rs m | 1,160 | 3,496 | 33.2% |
Indian Promoters | % | 0.0 | 40.4 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 37.4 | 53.4% | |
FIIs | % | 6.2 | 14.9 | 41.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 59.6 | 80.8% | |
Shareholders | 56,778 | 74,976 | 75.7% | ||
Pledged promoter(s) holding | % | 0.0 | 54.2 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | MEDPLUS HEALTH SERVICES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -0.72% | 0.45% |
1-Month | -1.15% | -1.50% | 2.55% |
1-Year | 0.73% | -8.69% | 56.14% |
3-Year CAGR | -8.76% | -15.61% | 15.22% |
5-Year CAGR | 4.97% | -9.68% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the MEDPLUS HEALTH SERVICES share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of MEDPLUS HEALTH SERVICES the stake stands at 40.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of MEDPLUS HEALTH SERVICES.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
MEDPLUS HEALTH SERVICES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of MEDPLUS HEALTH SERVICES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.